FRA approves offering 45.8% of Macro Group’s issued capital
Updated 1/23/2022 11:35:00 AM
ArabFinance: The Financial Regulatory Authority (FRA) has approved the publication of the prospectus of the public and private offering of up to 45.8% of Macro Group Pharmaceutical’s (Macro Capital) issued capital at a maximum price of EGP 6.05 per share, according to a statement.
The Egyptian Exchange (EGX) previously announced that its Listing Committee approved the listing of issued capital for Macro Group Pharmaceutical (Macro Capital).
Founded in 2002, Macro Group is a leading Egyptian cosmeceutical company based in Cairo.
